RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 121 filers reported holding RIGEL PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.03 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $1,589,000 | -4.1% | 1,346,904 | -8.2% | 0.41% | +10.5% |
| Q2 2022 | $1,657,000 | -62.2% | 1,466,678 | 0.0% | 0.37% | -61.1% |
| Q1 2022 | $4,385,000 | +12.6% | 1,466,678 | -0.2% | 0.95% | +4.2% |
| Q4 2021 | $3,894,000 | -39.5% | 1,469,604 | -17.1% | 0.92% | -28.7% |
| Q3 2021 | $6,435,000 | -13.1% | 1,772,730 | +3.9% | 1.28% | -2.1% |
| Q2 2021 | $7,402,000 | +41.4% | 1,705,553 | +11.4% | 1.31% | +36.7% |
| Q1 2021 | $5,234,000 | -6.5% | 1,530,490 | -4.3% | 0.96% | -10.0% |
| Q4 2020 | $5,595,000 | +70.7% | 1,598,649 | +17.1% | 1.06% | +42.8% |
| Q3 2020 | $3,277,000 | – | 1,365,286 | – | 0.75% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 9,105,691 | $30,140,000 | 5.99% |
| Sio Capital Management, LLC | 1,888,181 | $6,250,000 | 3.50% |
| DAFNA Capital Management LLC | 473,478 | $1,567,000 | 1.32% |
| Cormorant Asset Management, LP | 2,000,000 | $6,620,000 | 0.96% |
| Ghost Tree Capital, LLC | 1,100,000 | $3,641,000 | 0.68% |
| Rhenman & Partners Asset Management AB | 1,282,000 | $4,243,000 | 0.67% |
| Palo Alto Investors LP | 4,254,623 | $14,083,000 | 0.67% |
| NEA Management Company, LLC | 3,243,150 | $10,375,000 | 0.36% |
| Telemetry Investments, L.L.C. | 170,000 | $563,000 | 0.25% |
| NJ State Employees Deferred Compensation Plan | 355,000 | $1,175,000 | 0.22% |